Montelukast sodium市場規模、佔有率及成長分析（按劑型、應用及地區分類）－2026-2033年產業預測

預計到 2024 年，全球Montelukast sodium市場規模將達到 5,273.9 億美元，到 2025 年將成長至 6,070.2 億美元，到 2033 年將成長至 18,698.6 億美元，預測期（2026-2033 年將成長至 18,698.6 億美元，預測期（2026-2033 年）的複合年成長率為 15.1%。

全球Montelukast sodium市場正經歷顯著成長，主要受氣喘和過敏性鼻炎等呼吸系統疾病盛行率上升以及人口老化（老年人更容易患上這些疾病）的推動。日益嚴重的空氣污染加劇了過敏和氣喘症狀，從而增加了對Montelukast sodium的需求。醫療基礎設施的改善和治療指南的建議也進一步推動了市場擴張。此外，對創新製劑和聯合治療的持續研究有望擴大Montelukast的應用範圍。人工智慧 (AI) 在藥物研發中的應用、物聯網 (IoT) 在儲存條件監控中的應用以及區塊鏈在供應鏈透明度方面的應用等技術創新也在推動市場發展。這些創新不僅提高了藥物的安全性和可近性，也有助於企業在製藥業保持競爭優勢。

全球Montelukast sodium市場促進因素

全球Montelukast sodium市場成長的主要促進因素是呼吸系統疾病（包括氣喘和過敏性鼻炎）發生率的上升，以及空氣污染、吸菸、遺傳因素和生活方式改變等因素。隨著空氣污染加劇、都市化加快、氣候變遷和遺傳易感性等因素導致越來越多的人患有慢性呼吸系統疾病，對Montelukast sodium等有效藥物的需求也日益成長。這種日益加重的健康負擔使得呼吸系統疾病的治療方法需求顯著增加，進一步推動了這個重要治療領域的市場成長和擴張。

限制全球Montelukast sodium市場發展的因素

由於缺乏專利保護，Montelukast sodium市場面臨嚴峻挑戰，導致生產商之間競爭異常激烈。學名藥價格大幅降低，對品牌Montelukast sodium的銷售造成了負面影響。此外，低價進口Montelukast sodium的湧入進一步加劇了市場競爭，限制了國內生產商的成長機會。因此，這些因素阻礙因素了市場擴張，使得品牌產品難以在價格較低的替代品面前維持市場佔有率。這種競爭格局對Montelukast sodium市場構成了重大限制。

全球Montelukast sodium市場趨勢

隨著專利到期，全球Montelukast sodium市場正經歷顯著的變革時期，學名藥產量激增。這一趨勢的特點是，人們越來越傾向於選擇療效相同、價格更低的替代藥物，這使得非專利Montelukast sodium對患者、醫療服務提供者和政府醫療系統都極具吸引力。隨著多家製藥公司攜各自的非專利藥進入市場，競爭日益激烈，價格也隨之下降，藥物的可及性也得到提升。此外，嚴格的法規結構正在實施，以確保這些學名藥保持其安全性和有效性，最終創造出一個更充滿活力、更人性化的市場環境。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 案例研究
• 顧客購買行為分析

全球Montelukast sodium市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 吸入器
  • 乾粉
  • 計量噴霧型
  • 緩霧
• 噴霧器

全球Montelukast sodium市場規模（依劑型分類）及複合年成長率（2026-2033 年）

• 藥片
• 口服液
• 其他

全球Montelukast sodium市場規模（按藥物類別和複合年成長率分類）（2026-2033 年）

• 抗發炎藥
• 支氣管擴張劑
• 聯合治療

全球Montelukast sodium市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 氣喘
• 過敏性鼻炎
• 麻疹
• 其他用途

全球Montelukast sodium市場規模（依通路分類）及複合年成長率（2026-2033 年）

• 醫院藥房
• 零售藥房
• 網路藥房

全球Montelukast sodium市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Teva Pharmaceuticals USA Inc.（US）
• Merck & Co. Inc.（US）
• Cipla Limited（India）
• Morepen Laboratories（India）
• Sanofi Aventis SA（France）
• SUN PHARMA（India）
• Intas Pharmaceuticals Ltd（India）
• Delmar Chemicals Inc.（Canada）
• SK Capital（Apotex Inc）（Canada）
• Sanyo Chemical Industries Ltd（Japan）

結論與建議

Global Montelukast Sodium Market size was valued at USD 527.39 Billion in 2024 and is poised to grow from USD 607.02 Billion in 2025 to USD 1869.86 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026-2033).

The global montelukast sodium market is witnessing significant growth driven by the rising prevalence of respiratory conditions such as asthma and allergic rhinitis, coupled with an aging population more susceptible to these ailments. Increasing air pollution levels are exacerbating allergy and asthma cases, thereby boosting demand for montelukast sodium. Improvements in healthcare infrastructure and its endorsement in treatment guidelines further support market expansion. Additionally, ongoing research into innovative formulations and combination therapies is likely to broaden montelukast's applicability. The market is also evolving through technological advancements, including AI for drug development, IoT for monitoring storage conditions, and blockchain for supply chain transparency. These innovations not only enhance safety and accessibility but also help companies maintain a competitive edge in the pharmaceutical landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Montelukast Sodium market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Montelukast Sodium Market Segments Analysis

Global Montelukast Sodium Market is segmented by Product Type, Dosage Form, Drug Class, Application, Distribution Channel and region. Based on Product Type, the market is segmented into Inhalers and Nebulizers. Based on Dosage Form, the market is segmented into Tablets, Oral solutions and Others. Based on Drug Class, the market is segmented into Anti-inflammatory, Bronchodilators and Combination Therapy. Based on Application, the market is segmented into Asthma, Allergic rhinitis, Urticaria and Other applications. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Montelukast Sodium Market

The global Montelukast Sodium market is being propelled by the rising incidence of respiratory disorders, including asthma and allergic rhinitis, along with contributing factors like air pollution, smoking, genetic factors, and lifestyle changes. As more people face chronic respiratory conditions due to heightened air pollution, urbanization, climate changes, and genetic vulnerabilities, the demand for effective medications like Montelukast Sodium is on the rise. This increased health burden creates a significant need for treatments that address these respiratory issues, further fueling market growth and expansion in this critical therapeutic area.

Restraints in the Global Montelukast Sodium Market

The Montelukast Sodium market faces significant challenges due to the absence of patent protection, resulting in fierce competition among manufacturers. The presence of generic versions, often available at substantially lower prices, adversely affects the sales of branded montelukast sodium. Additionally, the influx of affordable imported montelukast sodium further complicates the situation by limiting the growth opportunities for domestic producers. As a result, these factors create a restrictive environment for market expansion, making it difficult for branded products to maintain their market share against cheaper alternatives. This competitive landscape poses considerable constraints on the Montelukast Sodium market.

Market Trends of the Global Montelukast Sodium Market

The Global Montelukast Sodium market is experiencing a significant shift driven by the expiration of patents, leading to a surge in generic manufacturing. This trend is characterized by the increasing preference for cost-effective alternatives that deliver equivalent efficacy, making generic montelukast sodium highly appealing to patients, healthcare providers, and government health systems alike. As various pharmaceutical companies enter the market with their generic offerings, competition is intensifying, resulting in lower prices and broader accessibility. Furthermore, stringent regulatory frameworks are being implemented to ensure that these generic versions maintain safety and effectiveness, ultimately shaping a more dynamic and consumer-friendly landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Montelukast Sodium Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Inhalers
  • Dry Powder
  • Metered Dose
  • Soft Mist
• Nebulizers

Global Montelukast Sodium Market Size by Dosage Form & CAGR (2026-2033)

• Market Overview
• Tablets
• Oral solutions
• Others

Global Montelukast Sodium Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Anti-inflammatory
• Bronchodilators
• Combination Therapy

Global Montelukast Sodium Market Size by Application & CAGR (2026-2033)

• Market Overview
• Asthma
• Allergic rhinitis
• Urticaria
• Other applications

Global Montelukast Sodium Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Global Montelukast Sodium Market Size & CAGR (2026-2033)

• North America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Teva Pharmaceuticals USA Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morepen Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Aventis SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SUN PHARMA (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delmar Chemicals Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK Capital (Apotex Inc) (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanyo Chemical Industries Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations